Clinical Therapeutics · Nov 19, 2026
Associations of GLP-1 Receptor Agonist Usage With Clinical Outcomes of Limb Osteomyelitis in Type 2 Diabetes
By Perng PC, Chang Y, Wong CE et al.
S Purpose Patients with type 2 diabetes are prone to limb osteomyelitis, a condition associated with high morbidity and mortality. The relationship between glucagon-like peptide-1 receptor agonist (GLP-1RA) use and outcomes in these patients remains unclear. Methods We performed a retrospective cohort study using a large federated database from 2015 to 2024. Adult patients with type 2 diabetes (ICD-10 E11) and limb osteomyelitis were identified. GLP-1RA exposure was defined as use within 6 months prior to the diagnosis of osteomyelitis. Patients with end-stage renal disease, malignancy, or human immunodeficiency virus infection were excluded. Outcomes included all-cause mortality, amputation, sepsis, major adverse cardiovascular events, acute respiratory distress syndrome, and acute kidney injury. Propensity score matching was applied to balance baseline characteristics and disease severity. Findings A total of 21,858 patients were identified. After propensity score matching, 2615 patients remained in each cohort with balanced baseline characteristics. GLP-1RA use was associated with lower mortality, with rates of 1.0% at 6 months (HR 0.48, 95% confidence interval [CI] 0.30–0.78) and 4.7% at 3 years (HR 0.62, 95% CI 0.49–0.78). Compared with non-users, GLP-1RA users also had lower risks of amputation, sepsis, acute respiratory distress syndrome, and acute kidney injury. No significant differences were observed in major adverse cardiovascular events at either 6 months (odds ratio [OR], 0.88; 95% CI, 0.74–1.04) or 3 years (OR, 0.89; 95% CI, 0.78–1.02). Implications Among patients with type 2 diabetes and limb osteomyelitis, GLP-1RA use was associated with lower risks of mortality, sepsis, acute respiratory distress syndrome, and acute kidney injury. These findings suggest a potential supportive role for GLP-1RAs in this high-risk population, although further studies are needed to clarify the underlying mechanisms.
doi.org/10.1016/j.clinthera.2026.10.011PubMed 43057933Populations